Steatotic Liver Disease Risk Scores Compared for Predicting Cirrhosis
Cirrhosis Can Recur After Liver Transplant
Impact of Alcohol Intake on Fibrosis Risk Varies by Sex, Liver Disease
Link Between Liver Fibrosis in MASLD, ASCVD Varies by Glycemic Status
About Half Have Meaningful Drop in Long COVID Symptoms by 36 Months
Genetic Screening Can ID Hemoglobinopathy Prevalence
Few Meet Major Clinical Response Criteria After Treatment Escalation for Lupus
Nonpharmacologic Therapy Cuts Opioid Use Disorder Risk With Low Back Pain
Steatotic Liver Disease Risk Scores Compared for Predicting Cirrhosis 
Cirrhosis Can Recur After Liver Transplant 
Impact of Alcohol Intake on Fibrosis Risk Varies by Sex, Liver Disease 
Link Between Liver Fibrosis in MASLD, ASCVD Varies by Glycemic Status 
About Half Have Meaningful Drop in Long COVID Symptoms by 36 Months 
Genetic Screening Can ID Hemoglobinopathy Prevalence 
Few Meet Major Clinical Response Criteria After Treatment Escalation for Lupus 
Nonpharmacologic Therapy Cuts Opioid Use Disorder Risk With Low Back Pain 
